|
WBP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.46540004972462E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.82360000223048E-08 |
| Normal-vs-Stage2 |
1.54392999999198E-05 |
| Normal-vs-Stage3 |
6.08669999999645E-05 |
| Normal-vs-Stage4 |
6.242100E-04 |
| Stage1-vs-Stage2 |
8.983600E-01 |
| Stage1-vs-Stage3 |
6.574800E-01 |
| Stage1-vs-Stage4 |
2.774800E-01 |
| Stage2-vs-Stage3 |
6.589400E-01 |
| Stage2-vs-Stage4 |
3.338600E-01 |
| Stage3-vs-Stage4 |
5.836000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17279996825204E-09 |
| Normal-vs-AfricanAmerican |
1.039650E-02 |
| Normal-vs-Asian |
1.346050E-02 |
| Caucasian-vs-AfricanAmerican |
2.471800E-01 |
| Caucasian-vs-Asian |
5.556600E-01 |
| AfricanAmerican-vs-Asian |
1.281440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3159000000762E-07 |
| Normal-vs-Female |
3.76910003208053E-09 |
| Male-vs-Female |
4.392200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.880200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.20060000011691E-07 |
| Normal-vs-Age(61-80Yrs) |
1.41620004612264E-09 |
| Normal-vs-Age(81-100Yrs) |
1.955590E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.267200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.594400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.875400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.302840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.904200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.414200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.180100E-02 |
| Normal-vs-Grade 2 |
9.22570000394529E-08 |
| Normal-vs-Grade 3 |
7.49380002496025E-09 |
| Normal-vs-Grade 4 |
1.963830E-03 |
| Grade 1-vs-Grade 2 |
6.292600E-01 |
| Grade 1-vs-Grade 3 |
5.502000E-01 |
| Grade 1-vs-Grade 4 |
7.949200E-01 |
| Grade 2-vs-Grade 3 |
8.677600E-01 |
| Grade 2-vs-Grade 4 |
1.199800E-01 |
| Grade 3-vs-Grade 4 |
7.464400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.02740005181579E-09 |
| Normal-vs-ccB subtype |
1.171450E-04 |
| ccA subtype-vs-ccB subtype |
5.188500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43109999961588E-07 |
| Normal-vs-N1 |
2.01089999999349E-05 |
| N0-vs-N1 |
3.574000E-01 |
|
|
